Women's Health
VIDEO: Stephanie Faubion, MD, reports on latest updates in women’s health
CHICAGO — In this video interview with Healio, Stephanie Faubion, MD, MBA, FACP, NCMP, IF, highlights recent research on women’s health, which she discussed during her presentation here.
VIDEO: Improving CVD risk prediction in women
CHICAGO — Heart disease is a leading health threat for women, according to C. Noel Bairey Merz, MD, FACC, FAHA, FESC, the director of the Barbra Streisand Women’s Heart Institute at Cedars-Sinai.
Fewer menopause symptoms, HT prescriptions among Black and Hispanic vs. white veterans
Reported menopause symptoms and prescriptions for hormone therapy were less common among Black and Hispanic female veterans, highlighting disparities in the discussion, documentation and management of menopause, according to researchers.
Enhertu receives breakthrough therapy designation for breast cancer subset
The FDA granted breakthrough therapy designation to fam-trastuzumab deruxtecan-nxki for treatment of adults with unresectable or metastatic HER2-low breast cancer, according to a press release from the agent’s manufacturer.
Black, Hispanic women with vitamin D deficiency may be at higher risk for breast cancer
Black/African American and Hispanic/Latina women who have low vitamin D concentrations may be more likely to be diagnosed with breast cancer than those with adequate concentrations, according to a study published in Cancer.
Women with long COVID experience more symptoms than men
Among people with a previous SARS-CoV-2 infection, women were more symptomatic than men — not just in the acute phase but also months later — according to a retrospective prospective study in the Journal of Women’s Health.
Progesterone use may increase risk for thyroid cancer in women with infertility
Among women with infertility, those using progesterone may have a higher risk for developing thyroid cancer compared with those who have never used progesterone, although the risk remains low, according to study results.
Aromatase inhibitors reduce breast cancer recurrence vs. tamoxifen for certain women
Use of an aromatase inhibitor instead of tamoxifen reduced the risk for breast cancer recurrence among premenopausal women with ER-positive disease who received ovarian suppression, according to a study published in The Lancet Oncology.
Suicide higher among physicians than general population
Incidence of suicide was higher among physicians than in the general population and affected female physicians significantly more than male, according to a study published in Psychiatry Research.
New HER2 assay may be needed to guide breast cancer treatment with trastuzumab deruxtecan
The use of current standard HER2 assays as diagnostic tests may result in misassignment of patients for treatment of breast cancer with trastuzumab deruxtecan, according to a study published in JAMA Oncology.